Literature DB >> 11425815

Use of fertility drugs and risk of ovarian cancer.

F Parazzini1, C Pelucchi, E Negri, S Franceschi, R Talamini, M Montella, C La Vecchia.   

Abstract

BACKGROUND: The potential association between fertility drugs and risk of ovarian cancer has been analysed using data from a case-control study conducted between January 1992 and September 1999 in four Italian areas.
METHODS: Cases were 1031 women (median age 56, range 18-79 years) with incident, histologically confirmed epithelial ovarian cancer. Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals for cases for a wide spectrum of acute, non neoplastic, non hormone-related conditions.
RESULTS: A total of 15 cases and 26 controls reported use of fertility drugs. The corresponding odds ratio (OR) was 1.3 (95% confidence interval 0.7-2.5). The OR was 1.2 for women reporting last use <25 years before interview and 1.3 for >25 years.
CONCLUSIONS: Considering calendar year at use, the OR was non-significantly above unity for women reporting fertility drug use after 1970. The OR was 0.6 among nulliparous women and 1.9 among parous ones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425815     DOI: 10.1093/humrep/16.7.1372

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

2.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

Review 3.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

4.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

Review 5.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

6.  Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.

Authors:  Allan Jensen; Heidi Sharif; Kirsten Frederiksen; Susanne Krüger Kjaer
Journal:  BMJ       Date:  2009-02-05

7.  Simultaneous serous cyst adenoma and ovarian pregnancy in an infertile woman.

Authors:  Mahbod Ebrahimi; Firoozeh Akbari Asbagh
Journal:  Int J Fertil Steril       Date:  2014-03-09

Review 8.  Fertility drugs, reproductive strategies and ovarian cancer risk.

Authors:  Federica Tomao; Giuseppe Lo Russo; Gian Paolo Spinelli; Valeria Stati; Alessandra Anna Prete; Natalie Prinzi; Marsela Sinjari; Patrizia Vici; Anselmo Papa; Maria Stefania Chiotti; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  J Ovarian Res       Date:  2014-05-08       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.